Reducing MAN1A2 expression, which involves the removal of sialic acid, was shown to alleviate muscular dystrophy symptoms, suggesting its potential importance in finishing precocity (Flanigan et al., 2021). This evidence concerns the gene MAN1A2 and muscular dystrophy.